Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer

Recruiting N/A Interventional Study
Prostate Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Male
Study type
Interventional
Purpose
Health Services Research
Participants needed
50 (estimated)
Sponsor
Henry Ford Health System · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a pilot study to improve rates of germline genetic testing for black patients with aggressive prostate cancer as recommended by the updated guidelines by the National Cancer Comprehensive Network (NCCN) in 2018. In this study, consented patients will undergo a low-risk intervention of an educational session with a trained staff member on germline testing in prostate cancer and, if agreeab…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Men, age greater than or equal to 18 years of age. 2. Men who racially identify as black or multiracial including black 3. Diagnosis of prostate cancer of any histology. 4. Must meet NCCN guidelines for germline testing 1. Men with very low, low or intermediate risk prost…
Contacts

Clara Hwang, MD

313-556-8830

chwang2@hfhs.org

CONTACT

Karthik Subramanian, MS

313-401-9815

ksubram3@hfhs.org

CONTACT